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Abstract
Background
We investigated whether maternal prenatal emotions are associated with gestational length
and birth weight in the large PREDO Study with multiple measurement points of emotions
during gestation.
Methods
Altogether 3376 pregnant women self-assessed their positive affect (PA, Positive and Neg-
ative Affect Schedule) and depressive (Center for Epidemiologic Studies Depression Scale,
CES-D) and anxiety (Spielberger State Anxiety Scale, STAI) symptoms up to 14 times dur-
ing gestation. Birth characteristics were derived from the National Birth Register and from
medical records.
Results
One standard deviation (SD) unit higher PA during the third pregnancy trimester was asso-
ciated with a 0.05 SD unit longer gestational length, whereas one SD unit higher CES-D
and STAI scores during the third trimester were associated with 0.04–0.05 SD unit shorter
gestational lengths (P-values 0.02), corresponding to only 0.1–0.2% of the variation in
gestational length. Higher PA during the third trimester was associated with a significantly
decreased risk for preterm (< 37 weeks) delivery (for each SD unit higher positive affect,
odds ratio was 0.8-fold (P = 0.02). Mothers with preterm delivery showed a decline in PA
and an increase in CES-D and STAI during eight weeks prior to delivery. Post-term birth (
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42 weeks), birth weight and fetal growth were not associated with maternal prenatal
emotions.
Conclusions
This study with 14 measurements of maternal emotions during pregnancy show modest
effects of prenatal emotions during the third pregnancy trimester, particularly in the weeks
close to delivery, on gestational length. From the clinical perspective, the effects were negli-
gible. No associations were detected between prenatal emotions and birth weight.
Introduction
Mounting empirical evidence suggests that maternal emotional distress during pregnancy,
including depressive symptoms, and state, trait and pregnancy-specific anxiety, may increase
the risk of adverse birth outcomes, such as preterm birth (< 37 0/7 gestational weeks) or
shorter length of gestation, intrauterine growth restriction (IUGR), and low (< 2.5 kg) or lower
birth weight at delivery [1–7]. However, the literature is relatively inconsistent, and includes
null associations as well [8]. The associations may also vary according to continuous or cate-
gorical treatment of the exposure and/or outcome variables, and the level of income in the
country in which the sample was derived [1,4,5,7].
A small body of literature suggests that maternal positive predisposition or positive attitude
towards pregnancy may, independently of emotional distress, decrease the risk of adverse birth
outcomes. In a sample of 130 pregnant women, higher levels of self-esteem and optimism mea-
sured in gestational weeks 28–30 were associated with higher birth weight, but not with length
of gestation [9]. Correspondingly, a higher level of dispositional optimism measured in gesta-
tional weeks 21–30 was associated with higher birth weight, but not with length of gestation
[10], among medically high-risk sample of 129 pregnant women. A more recent study in 169
pregnant women demonstrated that more positive attitudes towards pregnancy, measured on
average at gestational week 15, were associated with a longer length of gestation and a lower
risk of preterm delivery. This study additionally showed that a steeper increase in maternal
positive attitudes towards gestational weeks 19 and 30 was associated with a longer gestational
length, but it was not associated with prematurity [11]. While these studies provide important
insight into the potentially beneficial effects of positive characteristics, all of the existing studies
have been conducted in relatively small and/or selected samples and none have covered the
whole pregnancy. This has precluded testing whether the effects would vary according to the
timing of the exposure. In addition, the measurement of positive affect has mostly referred to
attitudes towards pregnancy or dispositional trait-like measures of the pregnant mother, and
less to state-like fluctuations in current affect.
Our original contribution in this study is to explore the influence of positive affect and the
role of the timing of exposures for the birth outcomes. To our knowledge, our study offers the
most comprehensive view on maternal emotional state over the course of pregnancy reported
thus far, with prospective assessments of emotions at two-week intervals from 12 weeks’ gesta-
tion onwards in a large data set. Therefore, the roles of negative affect and its timing were also
relevant. Hence, we examined the hypothesis that higher positive and lower negative affect
would predict longer length of gestation and higher birth weight in 3376 pregnant women. We
also examined whether the associations would vary by the medical risk-status of mothers, since
obstetric complications are associated with higher emotional distress during pregnancy [12].
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Methods
Participants
The participants came from the Prediction and Prevention of Preeclampsia (PREDO) Study
[13–15]. The PREDO is composed of two subsamples. For the high-risk subsample, we
recruited 973 singleton pregnant women with risk factors for preeclampsia and 110 singleton
pregnant women without known risk factors as a comparison group at 12 0/7–13 6/7 gesta-
tional weeks as previously described [13,15]. For the community-based subsample, we
recruited 3702 singleton pregnant women within the same pregnancy weeks. The recruit-
ment took place between September 2005 and February 2010 when these women attended
their first ultrasound scan in one of ten hospital maternity clinics participating in the
PREDO. Of the 4785 recruited mothers, we had data on birth outcomes from the birth regis-
ter and the two-week interval self-report of positive affect, depressive symptoms, and state
anxiety during pregnancy for 3376 mothers (70.6% of those recruited). Participants of the
study did not differ from mothers with missing data on prenatal emotions in subsample sta-
tus or birth outcome (P-values > 0.29), but were 0.9 year older (95% Confidence Interval
(CI) 0.6 to 1.2, P < 0.001), more often primiparous (40.7% vs. 33.9%, P < 0.001) and less
often obese before pregnancy (body mass index (BMI) > 30 kg/m2) (13.3% vs. 17.1%,
P = 0.002). The participants also less often smoked during pregnancy (3.3% vs. 9.3%,
P < 0.001) and more often had tertiary education (59.9% vs. 46.4%, P < 0.001). The charac-
teristics of the participants are presented in Table 1. The study protocol was approved by the
Ethical Committee of Helsinki University Central Hospital, and all participants signed an
informed consent.
Measurement of variables
Prenatal emotions. The participants filled in well-validated questionnaires [16–18] on
prenatal emotions at two week intervals throughout pregnancy from 120/7 to 13 6/7 gestational
weeks until delivery or until 38 0/7 to 39 6/7 gestational weeks. The questionnaires were filled
in up to 14 times during pregnancy.
Positive affect: We used Positive Affect (PA) scale comprising 10 mood states derived from
the International Positive and Negative Affect Schedule (PANAS) [18]. The participants were
asked to rate the extent to which they currently feel each mood state on a scale from 1 (not at
all) to 5 (very much).
Depressive symptoms: We used the Center for Epidemiologic Studies Depression Scale
(CES-D) (16) for both continuous and categorical variables: CES-D scores were dichotomized
at16, which is the cut-off for individuals at risk for clinically significant depressive symptoms
[16]. The participants were asked to rate the 20 questions covering the frequency of symptoms
experienced during the preceding week on a scale of 0 (not at all, less than one day) to 3 (all the
time / 5–7 days).
Anxiety symptoms: To measure state anxiety, we used the Spielberger State Anxiety Scale
(STAI) [17].The participants were asked to rate the 20 items covering the extent to which they
currently feel anxious on a scale from 1 (not at all) to 4 (very much so).
Birth outcomes. Data on gestational length and birth weight came from the hospital birth
records for the high-risk subsample and from the national birth register for the community-
based subsample. We used the birth outcome variables as both continuous and categorical vari-
ables: preterm birth: 36 6/7 gestational weeks; term birth: 37 0/7-41 6/7 gestational weeks;
post-term birth: 420/7gestational weeks; small for gestational age (SGA): birth weight for
gestational age -2 standard deviations (SD); appropriate for gestational age (AGA): birth
Prenatal Emotions and Birth Outcomes
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Table 1. Characteristics of the participants of the Predo-Study.
Continuous variables N Mean/N SD/% Range
PANAS 1st trimester 3200 30.3 7.9 10.0–50.0
2nd trimester 3357 30.2 7.0 10.0–50.0
3rd trimester 3240 30.3 7.8 10.0–50.0
CES-D 1st trimester 3205 11.5 7.9 0.0–50.0
2nd trimester 3357 11.1 6.5 0.0–48.7
3rd trimester 3240 11.8 7.1 0.0–48.5
STAI 1st trimester 3198 31.8 9.8 20.0–80.0
2nd trimester 3357 33.2 7.8 20.0–78.0
3rd trimester 3240 34.1 8.7 20.0–75.2
Social Support 1st trimester 3216 47.0 13.3 1.0–65.0
2nd trimester 3359 42.5 12.1 0.0–65.0
3rd trimester 3240 43.3 13.2 0.0–65.0
Birth weight (grams) 3363 3526.7 518.5 580–5490
Gestational length (weeks) 3376 39.9 1.6 27.7–42.7
Mother's age at delivery (years) 3376 31.8 4.7 17.0–47.4
Categorical variables
Birth outcome SGA 3363 80 2.4
LGA 3363 69 2.1
Premature 3376 130 3.9
Postterm 3376 186 5.5
Elective Cesarean section (yes) 3341 206 6.2
Parity 3376
Primiparous 1369 40.7
Multiparous 1997 59.3
Child's sex 3376
Boy 1741 51.6
Girl 1635 48.4
Mother's education 3371
Basic 91 2.7
Secondary 1258 37.3
Tertiary 2022 60.0
Mother’s prepregnancy BMI 3374
< 18.5 112 3.3
18.5–24.99 2180 64.6
25–29.99 641 19.0
>30 441 13.1
Alcohol consumption during pregnancy 3336
No 2802 84.0
Yes 534 16.0
Smoking during pregnancy 3374
No 3149 93.3
During 1st trimester 113 3.3
During and after 1st trimester 112 3.3
Hypertensive pregnancy disorders 3374
Normotension 2968 88.0
Gestational hypertension 142 4.2
Any preeclampsia 125 3.7
(Continued)
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weight for gestational age> -2 SD— 2SD; LGA: birth weight for gestational age 2 SDs, all
according to Finnish national growth charts [19].
Confounding variables. Maternal age (years), delivery mode (vaginal vs. Cesarean), parity
(primiparous vs. multiparous), smoking (no/quit during first trimester/smoked throughout
pregnancy) during pregnancy, and infant’s sex (girl vs. boy) were derived from the national
birth register for both subsamples. For the medical high-risk sample, maternal pre-pregnancy
BMI (underweight: BMI< 18.5 kg/m2; normal weight: BMI = 18.5 to 25 kg/m2; overweight;
BMI = 25 to 30 kg/m2; obese: BMI 30 kg/m2, hypertensive pregnancy disorders (preeclamp-
sia, gestational hypertension or chronic hypertension), gestational diabetes (hyperglycemia
that first emerged or was first identified during pregnancy), and Type I diabetes were derived
from patient case records and verified by a clinical jury. For the community-based subsample
the data of pregnancy disorders and BMI came from the national birth register. In both sub-
samples maternal education (primary:< 10 years; secondary: 10–12 years; tertiary:> 12 years)
prenatal use of antidepressant or other psychotropic medication (sedatives, barbiturates and
anti-psychotics) and alcohol consumption during pregnancy (yes/no) were self-reported in a
questionnaire given at the first ultrasound screening at gestational week 12 6/7-13 6/7. Social
support was assessed in at two-week intervals (i.e. biweekly) in the questionnaire with a 65 mm
long visual analog scale.
Statistical analyses
First, we used linear regression analyses to study associations between maternal positive affect,
depressive symptoms and state anxiety with birth outcomes as continuous variables. Trimes-
ter-specific prenatal emotions were tested in separate models. CES-D and STAI scores were
square-root- and logarithm-transformed to attain normality. All continuous variables were
standardized to the mean of 0 and SD of 1 to facilitate interpretation of effect sizes. Hence, the
unstandardized regression coefficients represent SD unit change per SD unit change. We calcu-
lated trimester mean scores of prenatal emotions (first trimester week 12 measurement; second
Table 1. (Continued)
Continuous variables N Mean/N SD/% Range
Chronic hypertension 139 4.1
Gestational diabetes 3374
No 3021 89.5
Yes 353 10.5
Type I diabetes 3374
No 3355 99.4
Yes 19 0.6
Antidepressant medication 2811
No 2734 97.3
Yes 77 2.7
Other psychotropic medications 2811
No 2791 99.3
Yes 20 0.7
PANAS, Positive and Negative Affect Schedule (only positive affect included); CES-D, Center for Epidemiologic Studies Depression Scale; STAI,
Spielberger State Anxiety Scale; SGA, Small for gestational age birth weight < -2 SD according to Finnish growth charts; LGA, Large for gestational age
birth weight > 2 SD according to Finnish growth charts; Preterm birth, birth < 37 0/7 weeks of gestation; Post-term birth, birth  42 0/7 weeks of gestation;
BMI, body mass index.
doi:10.1371/journal.pone.0150058.t001
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trimester means of scores during weeks 14–26; third trimester week 28 to delivery or to week
38). The rationale of using trimester means in these analyses instead of the bi-weekly scores
was based on the very high inter-correlations between the bi-weekly emotion scores (r range
0.41–0.80, all P-values< 0.001).
All analyses were adjusted for maternal age at delivery, parity, delivery mode, education and
infant’s sex (Model 1) and further for maternal alcohol consumption and smoking during preg-
nancy, maternal pre-pregnancy body mass index, hypertensive pregnancy disorders, gesta-
tional and Type I diabetes, antidepressant and other psychotropic medication, and social
support (Model 2). In case of significant associations, the explained variance (R2) was calcu-
lated for prenatal emotions by hierarchical multiple regression analyses. We used logistic
regressions to examine whether maternal positive affect decreased and depressive symptoms
and state anxiety increased the risk of preterm vs. term, post-term vs. term, SGA vs. AGA, and
LGA vs. AGA births. Finally, to test whether the associations varied by the medical risk status
of the sample, we added an interaction term ‘high-risk subsample vs. community subsample x
trimester-specific PA/CES-D/STAI’ to the regression equations following the main effects. In
these interaction analyses, the small comparison group recruited for the high-risk subsample
was merged to the community-based subsample.
Results
PA (range of Pearson r’s 0.57 to 0.83), CES-D (r’s 0.61 to 0.83) and STAI (r’s 0.55 to 0.79)
scores were significantly correlated across the three trimesters (all P-values< 0.001). PA corre-
lated negatively within the trimesters with STAI (r’s -0.51 to -0.66) and CES-D (r’s -0.50 to
-0.62). STAI and CES-D correlated positively with each other within the trimesters (r’s 0.69 to
0.84), all P-values< 0.001. In terms of mean raw scores shown in Table 1, CES-D and STAI
scores were significantly higher during the first and third trimesters compared to the second
trimester (all P-values< 0.001), and significantly higher during the third trimester than during
the first trimester (P-values 0.002). No mean score differences were found for PANAS (all P-
values 0.26).
Birth outcomes as continuous
Table 2 shows the trimester-specific associations between PA, CES-D and STAI and birth out-
comes. One SD unit increase in PA and one SD unit decrease in CES-D and STAI during the
third trimester were associated with 0.05 SD unit longer and 0.04 and 0.05 SD unit shorter ges-
tational length, respectively. These associations remained significant after we made adjust-
ments for the additional confounders in Model 2. PA, CES-D, and STAI at the first and second
trimesters were not associated with gestational length (P-values 0.17), and PA, CES-D, and
STAI at any trimester were not associated with birth weight (P-values 0.16). In hierarchical
multiple regression analyses, independent background variables (maternal age at delivery, par-
ity, delivery mode, education, infant’s sex, maternal alcohol consumption and smoking during
pregnancy, maternal pre-pregnancy BMI, hypertensive pregnancy disorders, gestational and
Type I diabetes, antidepressant and other psychotropic medication, and social support)
explained 8.7% of the variance in gestational length, whereas PA, CES-D or STAI during the
third trimester explained only 0.2%; 0.1% and 0.2% of the variance, respectively (P-
values 0.02 for the change).
Birth outcomes as categorical
PA during the third trimester was associated with a significantly decreased odds for preterm
delivery (for each SD unit increase in PA, the Odds Ratio (OR) decreased by 0.8-fold (95% CI
Prenatal Emotions and Birth Outcomes
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0.7; 1.0, P = 0.016 in Model 1; OR = 0.8, 95% CI 0.6; 1.0, P = 0.025 in Model 2) (these analyses
excluded two infants born before the third trimester). CES-D (OR = 1.2, 95% CI 1.0–1.4,
P = 0.066 in Model 1, P = 0.12 in Model 2), and STAI (OR 1.2, 95% CI 1.0–1.4, P = 0.091 in
Model 1; P = 0.26 in Model 2) scores during the third trimester, in turn, were higher in women
with a preterm delivery, but these associations were not statistically significant. PA, CES-D,
and STAI at the first and second trimesters were not associated with a preterm delivery (P-
values 0.44) and PA, CES-D, and STAI at any trimester were not associated with a post-term
delivery (P-values 0.20) or with SGA vs. AGA, or LGA vs. AGA status of the infant (P-
values 0.087).
Post-hoc exploratory analyses further highlighted the significance of the trajectories of emo-
tions experienced during pregnancy. Fig 1 shows the trajectories of standardized values of pre-
natal emotions in three groups divided by the gestational length (preterm, term, post-term). In
comparison with mothers with a term delivery, mothers with a preterm delivery showed a
decrease in PA (P = 0.002 for the difference between mean prenatal emotion score during the
last eight weeks of pregnancy and the mean score derived from earlier measurement points
during pregnancy) and an increase in both CES-D (P = 0.038) and STAI (P = 0.037) scores
towards the end of pregnancy.
Moderation by medical risk status of the sample
Medical risk status moderated significantly the associations between the third-trimester CES-D
and gestational length (P for high-risk vs community sample x CES-D interaction = 0.012 in
Model 1, P = 0.032 in Model 2, respectively). In the high-risk sample, one SD unit increase in
Table 2. The associations between prenatal positive affect, depressive and anxiety symptomswith birth outcome.
Gestational weeks SD Birth weight SD
Model 1 Model 2 Model 1 Model 2
B 95% CI B 95% CI B 95% CI B 95% CI
PANAS
1st trimester 0.01 -0.03;0.04 0.01 -0.03;0.04 -0.00 -0.04;0.03 -0.01 -0.04;0.03
2nd trimester 0.01 -0.02;0.04 0.01 -0.03;0.04 0.00 -0.03;0.03 -0.00 -0.03;0.04
3rd trimester 0.05** 0.01;0.08 0.05* 0.01;0.08 -0.01 -0.04;0.02 -0.00 -0.04;0.03
CES-D
1st trimester -0.01 -0.04;0.03 -0.00 -0.04;0.03 0.02 -0.02;0.05 0.02 -0.02;0.05
2nd trimester -0.02 -0.05;0.02 -0.02 -0.06;0.01 0.01 -0.02;0.05 0.01 -0.03;0.04
3rd trimester -0.04* -.007;-0.00 -0.04* -0.07;-0.00 0.02 -0.01;0.06 0.01 -0.02;0.05
STAI
1st trimester -0.02 -0.06;0.01 -0.03 -0.06;0.01 -0.01 -0.04;0.02 -0.01 -0.05;0.02
2nd trimester -0.02 -0.05;0.01 -0.02 -0.05;0.02 0.00 -0.03;0.04 0.00 -0.04;0.04
3rd trimester -0.05** -0.08;-0.02 -0.05* -0.08;-0.01 0.02 -0.02;0.05 0.01 -0.03;0.04
Model 1 was adjusted for child’s sex, parity, elective Cesarean section, and mother’s age at delivery and education; Model 2 was adjusted additionally for
prenatal alcohol use and smoking, mother’s pre-pregnancy BMI, hypertensive pregnancy disorders, gestational and Type I diabetes, antidepressant and
other psychotropic medication, and social support.
PANAS, Positive and Negative Affect Schedule (only positive affect included); CES-D, Center for Epidemiologic Studies Depression Scale; STAI,
Spielberger State Anxiety Scale.
*p  0.05
**p  0.01
doi:10.1371/journal.pone.0150058.t002
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the third trimester CES-D was associated with a 0.12 SD unit shorter gestational length (95%
CI -0.19 to -0.04, P = 0.003 in Model 1; P = 0.003 in Model 2); in the community sample this
association was not significant (P-values> 0.28).
Discussion
We investigated among 3376 women whether prenatal PA and depressive and anxiety symp-
toms were associated with the likelihood of shorter gestation, preterm birth or lower birth
weight. While the issue has been widely studied, the previous literature concentrates mostly on
negative emotions and does not cover the effect of the emotions experienced throughout the
entire pregnancy. With our data, we were able to overcome these issues with up to 14 measure-
ment points during pregnancy, allowing a trimester-specific approach, with an adjustment for
several major confounders. We found statistically significant, but clinically negligible associa-
tions between positive and negative emotions during the third trimester and gestational length,
and no significant associations with birth weight. In addition, PA during the third trimester
was associated with lower odds for a preterm birth.
PA was associated with longer gestational length and negative emotions with shorter gesta-
tional length. The general pattern of the results was in accordance with earlier studies [2–7],
which have not, however, provided trimester-specific information with multiple measurement
points, as done here. We found high correlations between the bi-weekly measurements of emo-
tions. Although this may suggest that measurement of emotions once in each trimester would
be sufficient for future studies, we would also like to point out that with increasing measure-
ment points, there is a decrease in measurement error, resulting in more reliable estimates of
prenatal emotions in each trimester. The observed associations held when the models were
adjusted for an extensive list of covariates. However, prenatal emotions independently
explained only 0.1–0.2% of the variation in gestational length, which is an extremely modest
amount. This effect corresponds to 12 hours’ shorter or longer gestation for each SD unit
change in prenatal emotions.
With regard to prematurity, higher PA during the third trimester was associated with a
reduced risk for a premature delivery, in line with a recent study [11]. However, they assessed
positive emotions only three times during the pregnancy. We also found a non-significant
trend for a higher risk of prematurity in those scoring higher on CES-D and STAI during the
third trimester, but these associations clearly declined in the fully adjusted models. If the mean
value of depressive symptoms was 16 points in CES-D in the third trimester, the risk for a
premature birth was 1.5-fold, but this association was not significant in either model. However,
the magnitude of this effect is in accordance with two meta-analyses on the relation between
prenatal depression and increased risk for prematurity [4,5]. Similar odds ratios were also
reported in the meta-analysis on the effects of prenatal anxiety on the risk of preterm birth [2].
Importantly, when we examined the prenatal affect during eight weeks prior to the delivery, we
found a significant decrease in PA and an increase in depressive and anxiety symptoms among
mothers with a preterm delivery, relative to mothers with term deliveries, again highlighting
the modest links between gestational length and prenatal emotions, particularly in the later
stages of gestation. In contrast, emotions during the first and second trimesters were unrelated
to gestational length.
Kramer [6] presented a large variety of different measures of acute and chronic stressors
and psychological distress to mothers in the second trimester and reported that of all forms of
Fig 1. Trajectories of maternal (A) positive affect (PANAS), (B) depressive symptoms (CES-D), and (C) anxiety symptoms (STAI) at two-week intervals
according to preterm ( 36 6/7 gestational weeks), term (37 0/7-41 6/7 gestational weeks) and post-term delivery ( 42 0/7 gestational weeks).
doi:10.1371/journal.pone.0150058.g001
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stress and psychological distress, only pregnancy-specific anxiety was associated with sponta-
neous preterm delivery, a finding that has been described before [10,20,21]. The authors specu-
lated that this result may also indicate a reversed causality since pregnancy-specific anxiety is
also a mother’s perception of potential medical risks. However, these concepts may interact;
pregnancy-specific and general anxiety influence each other over time, resulting in accumulat-
ing anxiety for some mothers during pregnancy [22].
We did not observe any associations of PA, prenatal anxiety, or depression with birth
weight. These findings are in line with a meta-analysis that noted no associations between
depression and birth weight [4] and with a study [8] focusing only on mothers with diagnosed
depressive/or anxiety disorders, and observing no associations with birth weight. However, our
findings are in contrast to other meta-analytic studies showing that maternal depression [5]
and anxiety [2] during pregnancy predict an increased risk of low birth weight, to the Genera-
tion R Study reporting an association between anxiety symptoms at the second trimester and
lower birth weight [23], and to studies showing that positive dispositions may be associated
with larger birth weight [9,10].
The current study subject has been under active research, with several biological mecha-
nisms potentially underlying associations between prenatal emotions and gestational length.
Increased concentration of corticotrophin-releasing hormone (CRH) in early pregnancy
plasma predicts preterm birth [24–26]. Most of the CRH during pregnancy is produced by the
placenta; this production is stimulated by circulating cortisol [27–29]. With CRH stimulating
cortisol secretion by the placenta and the fetal adrenal cortex, this has been suggested to create
a positive feedback loop ultimately leading to delivery [27–29]. However, the evidence for the
associations between maternal depression during pregnancy and elevated CRH concentrations
or cortisol levels is inconclusive including both positive [30–33] and null findings [6]. The pla-
centa plays a central role in regulating transfer of glucocorticoids to the fetus: The placental
enzyme 11-beta hydroxysteroid dehydrogenase type 2 (HSD2) metabolizes most of active
maternal cortisol to inactive cortisone, protecting the fetus from cortisol overexposure [34]. In
a subsample of term births in the current PREDO Study we quantified placental mRNA levels
of glucocorticoid (GR) and mineralocorticoid (MR) serotonin receptor genes as well as levels
of 11-beta HSD2 and 11-beta hydroxysteroid dehydrogenase type 1 (HSD1) [13,14]. We found
that maternal antenatal depression was associated with increased placental mRNA expression
of both MR and GR, thus increasing placental glucocorticoid sensitivity, and suggesting the
existence of a mechanism for increased fetal glucocorticoid exposure following maternal ante-
natal distress [14]. The associations were strongest for the third trimester depression scores.
We also reported an association between higher GR mRNA levels and shorter gestation within
the term range [13]. These results suggest that maternal antenatal mood is associated with pla-
cental glucocorticoid function, by both regenerating active glucocorticoids in placenta and
increasing sensitivity to glucocorticoids.
The strengths of this study include the large well-characterized sample and the multiple
repeated measurements of PA and anxiety and depressive symptoms, enabling us to reliably
evaluate the effects of these factors on gestation length and birth size and to assess specific sen-
sitivity periods. We were also able to assess possible confounding by multiple factors known to
affect gestation length and birth size.
As to limitations, we cannot rule out that the results, especially with regard to prematurity,
reflect reverse causality, i.e. prenatal emotions would be then generated as a response to the
risk of premature birth. Mothers in Finland are followed intensively during pregnancy, with
mothers being well aware of potential risks. Second, PA had a strong inverse correlation with
negative emotions. We cannot say whether PA had an independent effect on gestational length
or whether the effect could be reduced by a lack of negative emotions (depressive and anxiety
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symptoms). This is, however, a semantic question related to the core definition of positive emo-
tions and their relation to depression and anxiety. Third, we did not have information about
whether mothers with depression and anxiety symptoms received any psychosocial support.
Finally, the participants may not be representative of the catchment areas of the study hospi-
tals; these mothers had on average high educational attainment and smoking during pregnancy
was rare. This would be expected to cause bias only if the association between prenatal emo-
tions and pregnancy outcomes differs between participants and non-participants.
In summary, we used a large sample of pregnant women who rated their prenatal emotions
bi-weekly to examine the relationships of PA and depressive and anxiety symptoms with gesta-
tional length and birth weight. Experience of PA during the third trimester was associated with
longer gestation and lower odds of preterm delivery, whereas higher prenatal depressive and
anxiety symptoms during the third trimester were associated with shorter gestation. The asso-
ciations regarding depressive symptoms and gestational length were stronger among high-risk
mothers. We also found that the course of emotions during the last eight weeks of pregnancy is
different among women delivering preterm, as they displayed more negative emotions and less
PA. Birth weight and fetal growth were not associated with prenatal emotions, and no effects
on gestational length were observed for the first two trimesters. Our findings thus highlight the
modest effects of both positive and negative emotions during the third pregnancy trimester on
gestational length. While this subject has raised intense research interest in recent years, our
findings indicate that the effects of prenatal emotions on birth characteristics are very small.
The clinical relevance may be in the message that prenatal negative emotions, including
symptoms of depression and anxiety, may not play such a large role for pregnancy outcome
per se. Of course, this has to be verified in further studies with as intensive measurements of
prenatal emotions.
However, several studies show that prenatal negative emotions may be harmful to child
development, being associated with increased psychopathology in the offspring, often indepen-
dently of the maternal postnatal emotions [35–38]. As maternal prenatal emotions are likely to
persist to the postnatal period [39], there is however a risk for an accumulative risk for a less
optimal child development through less adaptive parent-child interaction patterns. New evi-
dence is also emerging on the links between maternal prenatal stress and emotions and epige-
netic programming of genes regulating the HPA axis in the offspring [40,41]. We have shown
that higher placental expression of genes regulating feto-placental glucocorticoid and serotonin
exposure is likely to mediate partly the associations between higher maternal depressive symp-
toms during the third trimester of pregnancy and regulatory behavioral challenges of the infant
[42]. Together with this evidence, our present findings suggest that the burden of maternal pre-
natal negative emotions to the child may be transferred otherwise than through the immediate
birth outcome.
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